# Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence

> **NCT04015765** · NA · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 376 (actual)

## Conditions studied

- Colorectal Cancer
- Polyp of Colon

## Interventions

- **PROCEDURE:** Hybrid Argon Plasma Coagulation and EMR procedure

## Key facts

- **NCT ID:** NCT04015765
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-26
- **Primary completion:** 2024-12-13
- **Final completion:** 2025-01-08
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2025-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04015765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04015765, "Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04015765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*